Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$2,889,078
-$294,323 QoQ
Shares Held
11,481
-21.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.20%
of 13F equity value
Holder Rank
#1,674
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Wealth Alliance Advisory Group, LLC holds $19,374,550 across 10 Drug Manufacturers - General names. ABBV ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,285 | $7,538,418 | |
| 2 | JNJ |
Johnson & Johnson
|
14,937 | $3,793,549 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
11,481 | $2,889,078 | |
| 4 | AMGN |
Amgen Inc
|
5,753 | $2,083,276 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,319 | $1,068,991 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
15,689 | $904,000 | |
| 7 | NVS |
Novartis AG
|
2,100 | $329,112 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,345 | $296,267 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,889,078 | 11,481 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $3,183,401 | 14,637 | Shares | Sole | 2026-04-09 | |
| 2025-12-31 | $3,070,677 | 13,439 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $3,104,488 | 13,408 | Shares | Sole | 2025-10-14 | |
| 2025-06-30 | $2,442,944 | 13,161 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $2,119,085 | 10,114 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $1,648,345 | 9,276 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,504,797 | 7,620 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $1,257,584 | 7,332 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,402,534 | 7,702 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $1,225,657 | 7,909 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $1,178,021 | 7,903 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $1,608,945 | 11,942 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $1,963,119 | 12,318 | Shares | Defined | 2023-05-02 | |
| 2022-12-31 | $1,580,545 | 9,780 | Shares | Sole | 2023-01-17 | |
| 2022-09-30 | $1,282,510 | 9,556 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $1,098,769 | 7,174 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $1,076,734 | 6,642 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $670,094 | 4,949 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $504,507 | 4,677 | Shares | Sole | 2021-10-08 | |
| 2021-06-30 | $463,400 | 4,114 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $445,217 | 4,114 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $472,960 | 4,414 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $386,622 | 4,414 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $464,587 | 4,732 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $347,274 | 4,558 | Shares | Sole | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||